Supriya Ghosh (Editor)

Glycyrrhizin

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Trade names
  
Epigen, Glycyron

ATC code
  
A05BA08 (WHO)

Formula
  
C42H62O16

Routes of administration
  
Oral, intravenous

Biological half-life
  
6.2-10.2 hours

Molar mass
  
822.94 g/mol

Glycyrrhizin The Sweetener Book

AHFS/Drugs.com
  
International Drug Names

Metabolism
  
Hepatic and by intestinal bacteria

Glycyrrhizin (or glycyrrhizic acid or glycyrrhizinic acid) is the chief sweet-tasting constituent of Glycyrrhiza glabra (liquorice) root. Structurally it is a saponin and has been used as an emulsifier and gel-forming agent in foodstuff and cosmetics. Its aglycone is enoxolone and it has therefore been used as a prodrug for that compound, for example it is used in Japan to prevent liver carcinogenesis in patients with chronic hepatitis C.

Contents

Glycyrrhizin FileGlycyrrhizin CASCCpng Wikimedia Commons

Medical uses

Glycyrrhizin Glycyrrhizin Glycyrrhizic Acid Dehydrogenase inhibitor Read

Glycyrrhizin inhibits liver cell injury and is given intravenously for the treatment of chronic viral hepatitis and cirrhosis in Japan. It has also proven itself effective in the treatment of autoimmune hepatitis in one clinical trial.

Adverse effects

Glycyrrhizin Proposed Pathway for Biosynthesis of Glycyrrhizin Figure 1 of 3

The most widely reported side effects of glycyrrhizin use are fluid retention. These effects are related to the inhibition of cortisol metabolism within the kidney, and the subsequent stimulation of the mineralocorticoid receptors. Other side effects include:

Mechanism of action

Glycyrrhizin httpsuploadwikimediaorgwikipediacommonsthu

It inhibits the enzyme 11beta-hydroxysteroid dehydrogenase, which likely contributes to its anti-inflammatory and mineralocorticoid activity. It has a broad-spectrum of antiviral activity in vitro against:

Pharmacokinetics

Glycyrrhizin Glycyrrhizinic acid Glycyrrhizin100mg productsenglish

After oral ingestion, glycyrrhizin is first hydrolysed to 18β-glycyrrhetinic acid by intestinal bacteria. After complete absorption from the gut, β-glycyrrhetinic acid is metabolised to 3β-monoglucuronyl-18β-glycyrrhetinic acid in the liver. This metabolite then circulates in the bloodstream. Consequently, its oral bioavailability is poor. The main part is eliminated by bile and only a minor part (0.31–0.67%) by urine. After oral ingestion of 600 mg of glycyrrhizin the metabolite appeared in urine after 1.5 to 14 hours. Maximal concentrations (0.49 to 2.69 mg/l) were achieved after 1.5 to 39 hours and metabolite can be detected in the urine after 2 to 4 days.

Organoleptic properties

It is 30-50 times as sweet as sucrose (table sugar).

Glycyrrhizin Nanoemulsions as vehicles for transdermal delivery of glycyrrhizin

Glycyrrhizin Liquorice versus SARS

Glycyrrhizin The use of glycyrrhizin for treating mastitis Patent 1208844

References

Glycyrrhizin Wikipedia